Amedeo Smart

Free Medical Literature Service

 

Amedeo

Gastric Cancer
  Free Subscription

Articles published in
BMC Cancer
    July 2026
  1. HARA T, Morimoto M, Kakehi M, Kamedani M, et al
    Combining fruquintinib with TAS-102 as a promising strategy: antitumor activity in preclinical colorectal and gastric cancer xenograft models.
    BMC Cancer. 2026;26:909.
    >> Share

  2. ZHU JY, Zhong Q, Yu JH, Wu D, et al
    Beyond TNM staging: validation of a CT-derived nutritional-inflammatory composite model (RFMmSIS) for prognostication in resectable gastric cancer.
    BMC Cancer. 2026;26:1067.
    >> Share

  3. YUKI S, Kawakami H, Harada K, Kubota Y, et al
    Study protocol of the C-SOLVE (JACCRO GC-12) trial; a randomized, non-comparative phase II trial of CapeOX or SOX plus zolbetuximab in HER2-negative, CLDN18.2-positive unresectable advanced gastric or esophagogastric junction cancer.
    BMC Cancer. 2026;26:1217.
    >> Share

  4. LIN Z, Xia LM, Wu Q, Xu X, et al
    Comparative contributions of visceral adiposity and muscle-related parameters to postoperative complications after gastrectomy: a domain-based analysis.
    BMC Cancer. 2026;26:1148.
    >> Share

  5. WANG W, Zhang X, Sun X, Wang L, et al
    Comparative efficacy and safety of first-line immunotherapy- and targeted therapy-based regimens for advanced gastric and gastroesophageal junction cancer: a network meta-analysis.
    BMC Cancer. 2026;26:1146.
    >> Share

  6. WANG X, Yu J, Sun Z, Sun Y, et al
    Integrated bioinformatic multi-omics analysis and experimental verification reveal the oncogenic role of WDHD1 and its underlying mechanism in gastric cancer progression.
    BMC Cancer. 2026 Jul 2. doi: 10.1186/s12885-026-16401.
    >> Share

    June 2026
  7. WU Y, Zhou J, Li S, Xuan Y, et al
    Perioperative NLR/PLR dynamic phenotypes and prediction of postoperative recurrence in locally advanced gastric cancer: a retrospective cohort study.
    BMC Cancer. 2026 Jun 30. doi: 10.1186/s12885-026-16431.
    >> Share

  8. TAWAKOLI MF, Salihee H, Rahmati A, Hatami MN, et al
    Correction: Hospital-based patterns of esophageal and gastric cancer cases at a major tertiary referral center in Kabul, Afghanistan: a retrospective case series.
    BMC Cancer. 2026;26:769.
    >> Share

  9. YOKOTANI Y, Sakamoto N, Matsuo M, Nakahata Y, et al
    Clinicopathological features and immune checkpoint expression patterns in dMMR early gastric cancer: a retrospective pilot study.
    BMC Cancer. 2026 Jun 15. doi: 10.1186/s12885-026-16298.
    >> Share

  10. KLEIN N, Shweiki D
    Sex differences in gastric cancer mutational burden reflect MLH1-associated epigenetic regulation.
    BMC Cancer. 2026 Jun 15. doi: 10.1186/s12885-026-16327.
    >> Share

    May 2026
  11. CHALAMILA A, Elias E, Ottoman O, Matiku S, et al
    Staining pattern and clinicopathological features of Epstein-Barr virus, Latent Membrane protein 1 expression in patients with gastric carcinoma in Lake zone, Tanzania.
    BMC Cancer. 2026 May 29. doi: 10.1186/s12885-026-16251.
    >> Share

  12. ZHOU F, Liu Z, Raj S, Luo B, et al
    Comparison of laparoscopic versus open approach surgery for gastric gastrointestinal stromal tumors in unfavorable surgical locations.
    BMC Cancer. 2026;26:823.
    >> Share

  13. QURESHI S, Qureshi MA, Zehra SM, Ahmed A, et al
    Progastricsin (Pepsinogen C) is downregulated in gastric adenocarcinoma: evidence from a South Asian population.
    BMC Cancer. 2026;26:817.
    >> Share

  14. YI W, Muhetaer K, Chen L, Ma X, et al
    Immunotherapy combined with chemotherapy as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction cancer: systematic review and Bayesian network meta-analysis based on specific PD-L1 expression levels.
    BMC Cancer. 2026;26:780.
    >> Share

  15. ZHENG Q, Xie X, Guo Q, Chen C, et al
    Prognostic value of tumor-infiltrating lymphocytes and common subtypes in patients with gastroenteropancreatic neuroendocrine neoplasms: a systematic review and meta-analysis.
    BMC Cancer. 2026;26:793.
    >> Share

    April 2026
  16. LI J, Zhao H, Sun P, Zhang Q, et al
    Prognostic value of preoperative Prognostic Nutritional Index (PNI) versus Neutrophil Lymphocyte Ratio (NLR) in gastric-cancer patients: a retrospective cohort study.
    BMC Cancer. 2026 Apr 30. doi: 10.1186/s12885-026-16106.
    >> Share

  17. BIEGLER O, Behrens HM, Haag J, Becker T, et al
    MYC amplification is common in cancer of the stomach and gastroesophageal junction, correlates with male sex and reduced response to neoadjuvant therapy.
    BMC Cancer. 2026;26:525.
    >> Share

  18. KIM E, Shin JY, Park S, Yoo JH, et al
    Treatment patterns and clinical outcomes of metastatic gastric cancer in South Korea: real-world evidence from retrospective electronic medical records data.
    BMC Cancer. 2026 Apr 20. doi: 10.1186/s12885-026-15811.
    >> Share

    March 2026
  19. TAWAKOLI MF, Salihee H, Rahmati A, Hatami MN, et al
    Hospital-based patterns of esophageal and gastric cancer cases at a major tertiary referral center in Kabul, Afghanistan: a retrospective case series.
    BMC Cancer. 2026 Mar 29. doi: 10.1186/s12885-026-15945.
    >> Share

  20. LIANG S, Huang Y, Li L, Zeng Q, et al
    A mechanistic study revealing that SLCO1B3 promotes gastric cancer development and metastasis through MAP1S expression downregulation.
    BMC Cancer. 2026 Mar 29. doi: 10.1186/s12885-026-15917.
    >> Share

  21. LIU X, Tian Y, Cao S, Li Z, et al
    Study protocol for hyperthermic intraperitoneal chemotherapy in the treatment of locally advanced gastric cancer after laparoscopic or robotic Gastrectomy with D2 lymphadenectomy: a phase III multicentre prospective randomized controlled clinical tria
    BMC Cancer. 2026 Mar 26. doi: 10.1186/s12885-026-15899.
    >> Share

  22. YESSULTANOVA G, Komekbay Z, Karibayeva I, Tulyayeva A, et al
    Prognostic implications of PD-L1 expression in gastric cancer: systematic review and meta-analysis of studies published between 2018 and 2025.
    BMC Cancer. 2026 Mar 23. doi: 10.1186/s12885-026-15880.
    >> Share

  23. HAN Y, Wang Q, Chen Y, Wu H, et al
    Platinum-free triplet therapy with nab-paclitaxel, S-1, and tislelizumab as first-line treatment for advanced gastric/gastroesophageal junction adenocarcinoma: a phase ii single-arm trial.
    BMC Cancer. 2026;26:546.
    >> Share

  24. YE F, Li J, Wang J, Fan J, et al
    Regulation of natural killer cell infiltration and tumor progression by CMTM6 in gastric cancer.
    BMC Cancer. 2026 Mar 16. doi: 10.1186/s12885-026-15855.
    >> Share

  25. FAZHI Z, Shangzhi H, Zhi D, Yang L, et al
    Integrating spatial lymph node patterns and multimodal clinicopathological features to predict post-neoadjuvant recurrence in gastric adenocarcinoma: a machine learning nomogram.
    BMC Cancer. 2026;26:484.
    >> Share

    February 2026
  26. CHENG K, Xu J, Yang J, Zhang Z, et al
    Spatial atlas of gastric cancer reveals macrophage-driven stromal activation via ICAM1(+) smooth muscle cells.
    BMC Cancer. 2026 Feb 27. doi: 10.1186/s12885-026-15647.
    >> Share

  27. VO DL, Huynh LAK, Vo DH, Nguyen THH, et al
    Multimodal analysis of cell-free DNA to improve early detection of gastric cancer.
    BMC Cancer. 2026 Feb 23. doi: 10.1186/s12885-026-15720.
    >> Share

  28. NIU X, Ma F, Li F, Wei C, et al
    Retraction Note: Integration of bioinformatics and cellular experiments unveils the role of SYT12 in gastric cancer.
    BMC Cancer. 2026;26:291.
    >> Share

  29. SENOCAK D, Karakullukcu M, Ozkan E, Bilgi O, et al
    Prognostic significance of the pan-immune-inflammatory value (PIV) in gastric cancer: a retrospective cohort study.
    BMC Cancer. 2026 Feb 17. doi: 10.1186/s12885-026-15759.
    >> Share

  30. WANG JF, Wei JM, He T, Hu JW, et al
    Mechanism of action of MiR-330-5p targeting ITGA5 in the regulation of proliferation, migration, and invasionof gastric cancer.
    BMC Cancer. 2026 Feb 11. doi: 10.1186/s12885-026-15676.
    >> Share

  31. CANASLAN K, Demirciler E, Celik S, Atila K, et al
    Prognostic stratification in gastric cancer with peritoneal metastasis: tumor biology and diagnostic modality as a surrogate for disease burden.
    BMC Cancer. 2026 Feb 4. doi: 10.1186/s12885-026-15684.
    >> Share

  32. NAM SK, Park J, Kwak Y, Batochir C, et al
    Multi-gene DNA methylation profiles of tumor suppressor genes for prognostic prediction in gastric cancer.
    BMC Cancer. 2026 Feb 3. doi: 10.1186/s12885-026-15620.
    >> Share

  33. FANG J, Yu Y, Sun Y, Chen X, et al
    Longitudinal plasma proteome profiling identifies IFN-gamma dynamics as a time-dependent predictor of immunotherapy response in advanced gastric cancer.
    BMC Cancer. 2026 Feb 2. doi: 10.1186/s12885-026-15623.
    >> Share

    January 2026
  34. ZHU G, Zhou S, Qu J, Jiao X, et al
    Construction and validation of a risk prediction model for perineural invasion in early gastric cancer based on multivariate analysis.
    BMC Cancer. 2026 Jan 19. doi: 10.1186/s12885-026-15583.
    >> Share

  35. LUO Y, Chen Y, Xu Q, Chen H, et al
    Supervised machine learning to quantitatively assess the prognostic value of tumor-infiltrating lymphocytes in gastric cancer.
    BMC Cancer. 2026 Jan 19. doi: 10.1186/s12885-025-15421.
    >> Share

  36. LIN X, Shi W, Zhou Z, Li D, et al
    Molecular features of early- vs. late-onset gastric cancer: a systematic review and meta-analysis.
    BMC Cancer. 2026 Jan 14. doi: 10.1186/s12885-026-15567.
    >> Share

  37. AKELLO VV, Ocan M, Kinengyere AA
    Histopathological subtypes and topographical subsites of gastric cancer in Sub-Saharan Africa: a scoping review.
    BMC Cancer. 2026 Jan 13. doi: 10.1186/s12885-026-15560.
    >> Share

  38. LI J, Wang FL, Yang TT, Yu XL, et al
    beta-ionone synergizes with 5-Fluorouracil to inhibit gastric cancer progression through PAX6-mediated cell cycle arrest.
    BMC Cancer. 2026 Jan 9. doi: 10.1186/s12885-026-15540.
    >> Share

  39. LI Y, Zhang Y, Zhao H, Wang Z, et al
    Incorporating tumor deposits into the TNM staging of gastric cancer: a retrospective cohort study for prognostic validation and staging optimization.
    BMC Cancer. 2026 Jan 3. doi: 10.1186/s12885-025-15526.
    >> Share

    December 2025
  40. NIKONEZHAD B, Shahriarizade M, Zamani A, Mahdevar M, et al
    Silencing TMEM105 suppresses gastric cancer cell growth and migration via proliferation-associated pathways.
    BMC Cancer. 2025 Dec 30. doi: 10.1186/s12885-025-15522.
    >> Share

  41. OH HJ, Kim CH, Park HW, Park B, et al
    Quantifying the effects of the Correa pathway from Helicobacter pylori infection to gastric cancer: causal inference found in 6.8 million Koreans.
    BMC Cancer. 2025 Dec 29. doi: 10.1186/s12885-025-15507.
    >> Share

  42. XU Y, Wei Z, Li M, Yang W, et al
    Identification and prioritization of high-frequency biomarkers and therapeutic targets in gastric cancer trials.
    BMC Cancer. 2025 Dec 26. doi: 10.1186/s12885-025-15484.
    >> Share

  43. LU FY, Huang X, Zhang K, Yin X, et al
    Development and validation of a diagnostic and screening method for gastric cancer by combining new gastric cancer screening score and serum biomarkers: a prospective study.
    BMC Cancer. 2025 Dec 17. doi: 10.1186/s12885-025-15379.
    >> Share

  44. WU J, Yi Y, Wang Q, Qiao J, et al
    5-Hydroxytryptamine receptor 1D overexpression exacerbates gastric cancer proliferation, invasion, and angiogenesis by activating the Wnt/beta-catenin signaling.
    BMC Cancer. 2025 Dec 11. doi: 10.1186/s12885-025-15423.
    >> Share

  45. CHEN L, Xu J, Li J, Ji K, et al
    The value of translational therapy in the treatment of advanced hepatoid adenocarcinoma of stomach.
    BMC Cancer. 2025 Dec 10. doi: 10.1186/s12885-025-15442.
    >> Share

  46. YU S, Sun Y, Zhou J, Sun C, et al
    Dynamic CEA kinetics as a prognostic biomarker for HER2-negative advanced gastric cancer treated with chemoimmunotherapy.
    BMC Cancer. 2025;25:1857.
    >> Share

  47. LI L, Zhang YH, Wang HJ, Wang YY, et al
    ASPN was higher expression in gastric cancer and associated with poor prognosis through promoting invasion and migration and inducing macrophage M2 polarization.
    BMC Cancer. 2025;25:1851.
    >> Share

    November 2025
  48. XIN R, Ma X, Niu M, Hao Q, et al
    Comprehensive long-read transcriptomic analysis reveals multi-level transcriptional alterations mediated by miR-214-3p dysregulation in gastric cancer cells.
    BMC Cancer. 2025 Nov 29. doi: 10.1186/s12885-025-15323.
    >> Share

  49. CHEN Y, Liu D, Sun K, Lin Y, et al
    Unsupervised machine learning reveals prognostic value of dynamic carbohydrate antigen 125 trajectory in gastric cancer.
    BMC Cancer. 2025;25:1834.
    >> Share

  50. TRIEMSTRA L, Spruijt SWJM, Vriens D, Vegt E, et al
    [(18)F]F-FAPI PET/CT and LAparoscopy in STagIng advanced gastric Cancer: a multicenter prospective study (PLASTIC-3 study).
    BMC Cancer. 2025 Nov 27. doi: 10.1186/s12885-025-15347.
    >> Share

  51. MOURDI N, Wu Y, Su Y, Zhao Y, et al
    The role of indocyanine green in the intraoperative navigation of gastric cancer surgery: a systematic review and meta-analysis.
    BMC Cancer. 2025 Nov 26. doi: 10.1186/s12885-025-15306.
    >> Share

  52. ZHU M, Hu Q, Lu Y, Xu Q, et al
    Quercetin inhibits gastric cancer cell proliferation and migration and is associated with the suppression of the IDO1-Kynurenine-AhR axis.
    BMC Cancer. 2025 Nov 25. doi: 10.1186/s12885-025-15308.
    >> Share

  53. SAFI MH, Hui Z, Xiaoyong W, Bingtuan L, et al
    Endoscopic submucosal dissection: a safe alternative to surgical intervention for young patients under 45 years of age with early gastric cancer. ESD vs. surgery in young EGC patients.
    BMC Cancer. 2025 Nov 22. doi: 10.1186/s12885-025-15293.
    >> Share

  54. YI S, Cai Q, Dong W, Lan W, et al
    Development and validation of a simple prediction risk score for predicting risk of gastric cancer in outpatient department.
    BMC Cancer. 2025 Nov 22. doi: 10.1186/s12885-025-15294.
    >> Share

  55. YU X, Su L, Lu R, Zhao S, et al
    Erythrocyte lifespan for predicting moderate and severe anemia in advanced gastric cancer patients post-anti-tumor therapeutics: a prospective study.
    BMC Cancer. 2025;25:1791.
    >> Share

  56. EROGLU I, Mohring C, Sadeghlar F, Manczak A, et al
    Efficacy and safety of neoadjuvant FLOT treatment for resectable gastric/gastroesophageal junction adenocarcinoma in Turkish and German patients; a real-world data.
    BMC Cancer. 2025;25:1754.
    >> Share

  57. MA Z, Ma B, Chen M, He P, et al
    KLC3 drives gastric cancer progression by stabilizing SLC2A5 to activate MAPK signaling and promote epithelial-mesenchymal transition.
    BMC Cancer. 2025;25:1746.
    >> Share

  58. QIU L, Yao S, Yang Z, Zhou Z, et al
    Development and validation of a novel nerve-related prognostic model for gastric cancer based on bulk and single-cell RNA sequencing data.
    BMC Cancer. 2025;25:1738.
    >> Share

  59. ZHANG Z, Lin Z, Xu Y, Luo L, et al
    Toripalimab combined with FLOT chemotherapy as conversion therapy for gastric cancer with peritoneal metastasis: a single-arm, open-label, phase II trial.
    BMC Cancer. 2025;25:1733.
    >> Share

  60. LIN Y, Chen H, Wei C, Luo D, et al
    Tumor index predicts recurrences of patients with pathological stage ? gastric cancer after radical surgical resection.
    BMC Cancer. 2025;25:1727.
    >> Share

  61. ZHONG F, Zhang M, Xu L, Cui J, et al
    Deciphering mismatch repair protein expression variability in gastric cancer: clinical and prognostic implications.
    BMC Cancer. 2025;25:1699.
    >> Share

  62. LIANG C, Yu Z, Hou S, Jia C, et al
    Therapeutic efficacy of multiple neoadjuvant regimens involving targeted therapy, immunotherapy and chemotherapy in gastric cancer: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:1694.
    >> Share

    October 2025
  63. WEI H, Yuan L, Li Y, Xia Y, et al
    Global status and attributable risk factors of esophageal, stomach, colorectal cancers in adolescents and young adults: global burden of disease 2021 study analysis.
    BMC Cancer. 2025;25:1682.
    >> Share

  64. LIU W, Peng ZZ, Zhang T, Liao K, et al
    Burden, trends, driving factors, and predictions of gastric cancer: a cross-national comparative analysis of China, Japan, and South Korea.
    BMC Cancer. 2025;25:1669.
    >> Share

  65. PURANIK AD, Dev ID, Yadav S, Rangarajan V, et al
    PReCedeNT trial: Phase III randomized-controlled trial of Lutetium - 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
    BMC Cancer. 2025;25:1659.
    >> Share

  66. YANG J, Li J, Deng Q, Chen Z, et al
    Retraction Note: Effect of neoadjuvant chemotherapy combined with arterial chemoembolization on short-term clinical outcome of locally advanced gastric cancer.
    BMC Cancer. 2025;25:1663.
    >> Share

  67. SUN QH, Yin ZX, Li Z, Tian SB, et al
    Retraction Note: miR-874 inhibits gastric cancer cell proliferation by targeting SPAG9.
    BMC Cancer. 2025;25:1658.
    >> Share

  68. GE S, Wang F, Li H, Yang Y, et al
    The combination of anti-PD-1 antibodies, trastuzumab and chemotherapy may improve the outcome of some patients with HER2-positive alpha-fetoprotein-producing gastric cancer: a retrospective real-world analysis from a single center.
    BMC Cancer. 2025;25:1549.
    >> Share

  69. SIMONYAN RM, Babayan MA, Yekmalyan HH, Simonyan SG, et al
    Thermostable enzyme isoforms, continuously producing monocomponent superoxide radicals, from human postoperative serous fluids: isolation and properties.
    BMC Cancer. 2025;25:1555.
    >> Share

  70. LU Y, Wu J, Yang T, Lian L, et al
    Global, regional, and national burdens of early onset gastric cancer aged 15-49 years from 1990 to 2021 with projections to 2035: a population-based study.
    BMC Cancer. 2025;25:1533.
    >> Share

  71. ZHANG X, Jing Z, Yu A, Xu X, et al
    High sodium intake: a silent killer driving global gastric cancer burden.
    BMC Cancer. 2025;25:1517.
    >> Share

  72. LIU Y, He W, Wu Q, Ji JF, et al
    Establishment of a Chinese library of patient-derived xenografts from gastrointestinal cancers.
    BMC Cancer. 2025;25:1508.
    >> Share

  73. LI X, Wang J, Ma Y, Wang S, et al
    Burden and trends of early-onset gastric cancer in the 11 BRICS countries (2025 expansion): 1990-2021 with projections to 2035.
    BMC Cancer. 2025;25:1478.
    >> Share

    September 2025
  74. LIANG B, Na Z, Wang K
    Predictive value of (18)F-FDG PET/CT metabolic parameters for gastric cancer patients' microsatellite instability status.
    BMC Cancer. 2025;25:1457.
    >> Share

  75. ZOU F, Deng S, Liu B, Chen M, et al
    Multi-omics analysis reveals disrupted gut microbiota and metabolism in gastric cancer patients with high SIRI.
    BMC Cancer. 2025;25:1433.
    >> Share

  76. SUN Y, Hou L, Zhao E
    Correction: Short-term outcomes of laparoscopic D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in distal gastric cancer patients with high body mass index.
    BMC Cancer. 2025;25:1420.
    >> Share

    August 2025
  77. GAO X, Li Z, Yuan J, Mei X, et al
    Comparison of short- and long-term outcomes among total laparoscopic, laparoscopic-assisted, and open total gastrectomies for advanced gastric cancer patients after neoadjuvant chemotherapy: a multicenter retrospective cohort study.
    BMC Cancer. 2025;25:1401.
    >> Share

  78. SHANSHAN W, Lian W, Lu D, Liping L, et al
    Best practices for home nutritional management in postoperative gastric cancer patients: an evidence summary.
    BMC Cancer. 2025;25:1399.
    >> Share

  79. ZHANG R, Chen X, Chen G, Zhao Z, et al
    Novel surveillance protocol for gastric cancer based on CEA: a high-volume multi-center study.
    BMC Cancer. 2025;25:1396.
    >> Share

  80. ZENG T, Ling X, Chen S, Yang J, et al
    Prognostic value of nutritional risk assessment indices in patients with digestive system tumors.
    BMC Cancer. 2025;25:1385.
    >> Share

  81. WU H, Shu W, Ding Y, Li Q, et al
    The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy.
    BMC Cancer. 2025;25:1369.
    >> Share

  82. YUE HY, Yang XT, Zhang JC, Zhou P, et al
    Impacts of omega-3 fatty acids intervention on immune functions and clinical outcomes in surgical gastric cancer patients: a systematic review and trial sequential meta-analysis.
    BMC Cancer. 2025;25:1366.
    >> Share

  83. WANG L, Yang F, Dong Q, Tung TH, et al
    Anti-PD-1 therapy achieves favorable outcome in gastric cancer combined with chronic hepatitis B.
    BMC Cancer. 2025;25:1354.
    >> Share

  84. ZHAI XM, Yang YQ, Lin L, Luo HC, et al
    CircMORC1 downregulated in plasma EVs promotes gastric cancer cell proliferation and invasion via miR-103a-1-5p sponging.
    BMC Cancer. 2025;25:1313.
    >> Share

  85. GAO Z, Guo Y, Yue C, Wang Y, et al
    Impact of anastomotic orientation (Upward vs. Downward) in Roux-en-Y reconstruction on duodenal stump leakage incidence after radical total gastrectomy: a retrospective comparative study.
    BMC Cancer. 2025;25:1312.
    >> Share

  86. HUANG Y, Huang Z, Hou W, Wang C, et al
    Cachexia index as a biomarker for cancer cachexia and quality of life in patients with gastric cancer.
    BMC Cancer. 2025;25:1293.
    >> Share

  87. LUAN X, Han X, Wang Z, Zhao L, et al
    Heterogeneity of metastatic gastric cancer: solitary non-regional lymph node metastasis and solitary lung metastasis showed better survival outcomes than other metastatic patterns.
    BMC Cancer. 2025;25:1287.
    >> Share

  88. XIA S, Xia Y, Liu T, Luo Y, et al
    Application of deep learning models in gastric cancer pathology image analysis: a systematic scoping review.
    BMC Cancer. 2025;25:1257.
    >> Share

    July 2025
  89. LIN CR, Wang MX, Guo XY, Huang YX, et al
    Global trends and sociodemographic inequalities in smoking and high-salt diet attributable to gastric cancer: a secondary analysis based on the global burden of disease 2021 study.
    BMC Cancer. 2025;25:1248.
    >> Share

  90. CHEN Y, Liu D, Wang Z, Lin Y, et al
    Machine learning-based dynamic CEA trajectory and prognosis in gastric cancer.
    BMC Cancer. 2025;25:1221.
    >> Share

  91. JUMAI N, Chen L, Lin X, He Q, et al
    Identification of gastroenteropancreatic neuroendocrine tumor patients with high liver tumor burden based on clinicopathological features.
    BMC Cancer. 2025;25:1217.
    >> Share

  92. WEI J, Xue S, Du X, Dai Y, et al
    DNMT1 blocks SOX21-repressed CKS2 transcription to promote gastric cancer progression.
    BMC Cancer. 2025;25:1182.
    >> Share

  93. TANPRASERT P, Chakrabandhu B, Yodkeeree S, Dejkriengkraikul Limtrakul P, et al
    Survival benefit of conversion surgery after intravenous 5-fluorouracil-based chemotherapy in unresectable advanced gastric cancer: a retrospective cohort study.
    BMC Cancer. 2025;25:1160.
    >> Share

  94. YANG L, Zhang Q, Zhang H, Shi H, et al
    Nutrition impact symptoms as prognostic indicators in gastric cancer: the role of quality of life and survival outcomes.
    BMC Cancer. 2025;25:1037.
    >> Share

  95. GUO F, Wang D, Zhang L, Fang Y, et al
    Efficacy and safety of anti-PD-1 antibodies plus small molecule anti-angiogenic drugs and chemotherapy in gastric cancer peritoneal metastasis: a multicenter real-world study.
    BMC Cancer. 2025;25:1028.
    >> Share

  96. YANG J, Xu W, Wang S, Yu Z, et al
    Comprehensive multi-omics pan-cancer analysis revealed EGFLAM as a potential prognostic and immune infiltration-associated biomarker.
    BMC Cancer. 2025;25:1109.
    >> Share

  97. HUANG Y, Hu Y
    Impact of helicobacter pylori infection on the efficacy of ICIs in gastric cancer.
    BMC Cancer. 2025;25:1101.
    >> Share

  98. CHEN Q, Yao Z, Duan J, Zhang Y, et al
    The levels of plasma MiR-9 and MiR-106a are associated with the development of peritoneal carcinomatosis in patients with gastric cancer.
    BMC Cancer. 2025;25:1090.
    >> Share

    June 2025
  99. MA Y, Li Y, Lin Z, Wang J, et al
    Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis.
    BMC Cancer. 2025;25:1010.
    >> Share

  100. TUOHUTI T, Abulizi K, Li T
    Short-term outcomes of robotic vs. laparoscopic surgery for gastric cancer after neoadjuvant therapy: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:1002.
    >> Share

  101. WANG Y, Li Y, Guo Y, Jiang S, et al
    Lipid accumulation product and visceral adiposity index as independent predictors of long-term survival after gastric cancer immunotherapy.
    BMC Cancer. 2025;25:1009.
    >> Share

  102. SONG S, Zhang X, Cui P, He W, et al
    Plasma cfDNA multi-omic biomarkers profiling for detection and stratification of gastric carcinoma.
    BMC Cancer. 2025;25:1003.
    >> Share

  103. LAN N, Lai M, Gao Y, Wang X, et al
    The mediating role of postoperative blood glucose in the relationship between body composition and overall survival in non-diabetic gastric cancer patients.
    BMC Cancer. 2025;25:995.
    >> Share

  104. WU YY, Lee LC, Zeng H, Gu Y, et al
    Synergistic effects of PD-1 antibody and chemotherapy followed by surgery-centric local treatment in patients with limited-metastatic gastric or gastroesophageal adenocarcinoma (ROSETTE trial): an open-label, single-center, randomized phase 2 trial.
    BMC Cancer. 2025;25:981.
    >> Share

    May 2025
  105. DU K, Hu W, Gao S, Gan J, et al
    Identification of multiomics and immune infiltration-associated biomarkers for early gastric cancer: a machine learning-based diagnostic model development study.
    BMC Cancer. 2025;25:972.
    >> Share

  106. ZHANG M, Bai L, Chen J, Meng Q, et al
    Clinical benefit of continuation of PD-1 inhibitors after progression on first-line chemoimmunotherapy in metastatic gastric cancer and biomarker exploration.
    BMC Cancer. 2025;25:935.
    >> Share

  107. ZHANG B, Chen Y, Gu X, Zheng Y, et al
    Fucosyltransferase 11 restrains ferroptosis via upregulation GPX4 expression in gastric cancer.
    BMC Cancer. 2025;25:923.
    >> Share

  108. LI H, Chen H, Zhao T, Zhang W, et al
    CD2AP shapes a stromal reduced tumor microenvironment and contributes to immunotherapy in gastric cancer.
    BMC Cancer. 2025;25:910.
    >> Share

  109. ZHANG C, Wang K, Zhang Z, Zhao X, et al
    Safety and short?term outcomes of a modified tubular esophagogastrostomy versus double tract reconstruction after proximal gastrectomy: a propensity score matching analysis.
    BMC Cancer. 2025;25:908.
    >> Share

  110. FAN S, Jiang H, Xu Q, Shen J, et al
    Risk factors for pneumonia after radical gastrectomy for gastric cancer: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:840.
    >> Share

  111. LING T, Zuo Z, Huang M, Ma J, et al
    Stacking classifiers based on integrated machine learning model: fusion of CT radiomics and clinical biomarkers to predict lymph node metastasis in locally advanced gastric cancer patients after neoadjuvant chemotherapy.
    BMC Cancer. 2025;25:834.
    >> Share

    April 2025
  112. RAFIEPOOR H, Banoei MM, Ghorbankhanloo A, Muhammadnejad A, et al
    Exploring the potential of machine learning in gastric cancer: prognostic biomarkers, subtyping, and stratification.
    BMC Cancer. 2025;25:809.
    >> Share

  113. LIU G, Cao S, Liu X, Tian Y, et al
    Effect of perioperative probiotic supplements on the short-term clinical outcomes of patients undergoing laparoscopic or robotic radical gastrectomy after neoadjuvant chemotherapy: Study protocol for a multicenter randomized controlled trial (GISSG202
    BMC Cancer. 2025;25:776.
    >> Share

  114. GUO H, Chen S, Zheng T, Ding P, et al
    Association of low skeletal muscle mass and radiodensity with clinical outcomes in patients undergoing robotic radical gastric cancer surgery: a population-based retrospective cohort study.
    BMC Cancer. 2025;25:741.
    >> Share

  115. BU S, Wang S, Wang T, Xing H, et al
    Efficacy and safety of XELOX combined with neoadjuvant radiotherapy versus neoadjuvant chemotherapy in locally advanced gastric cancer.
    BMC Cancer. 2025;25:731.
    >> Share

  116. FU M, Wang X, Zhou J, Wang J, et al
    Incidence and risk factors of sarcopenia in gastric cancer patients: a meta-analysis and systematic review.
    BMC Cancer. 2025;25:711.
    >> Share

  117. WU GF, He CH, Xi WT, Zhai WB, et al
    Sarcopenia defined by the global leadership initiative in sarcopenia (GLIS) consensus predicts adverse postoperative outcomes in patients undergoing radical gastrectomy for gastric cancer: analysis from a prospective cohort study.
    BMC Cancer. 2025;25:679.
    >> Share

  118. BABA K, Suzuki N, Imamura CK, Booka E, et al
    A phase I/II trial evaluating the safety of increased-dose S- 1 with oxaliplatin and nivolumab in HER2-negative advanced gastric cancer.
    BMC Cancer. 2025;25:675.
    >> Share

  119. ZHANG C, Wang T, Yuan J, Wang T, et al
    Potential predictive value of CD8A and PGF protein expression in gastric cancer patients treated with neoadjuvant immunotherapy.
    BMC Cancer. 2025;25:674.
    >> Share

  120. SHAO Y, Chen C, Yu X, Yan J, et al
    Comprehensive analysis of scRNA-seq and bulk RNA-seq data via machine learning and bioinformatics reveals the role of lysine metabolism-related genes in gastric carcinogenesis.
    BMC Cancer. 2025;25:644.
    >> Share

  121. NASCA V, Bergamo F, Foltran L, Antonuzzo L, et al
    Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical
    BMC Cancer. 2025;25:633.
    >> Share

  122. KONG PF, Yan YH, Duan YT, Fang YT, et al
    Comparative genomic analysis of Helicobacter pylori isolates from gastric cancer and gastritis in China.
    BMC Cancer. 2025;25:628.
    >> Share

  123. MA GF, Huang YY, Chen YC, Luo Z, et al
    Premature death patterns and trends of stomach cancer in Pudong, Shanghai: a population based study.
    BMC Cancer. 2025;25:618.
    >> Share

  124. XIN X, Tang Y, Lu M, Huang J, et al
    Prognostic value of diffusion-weighted imaging to cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for patients with gastric cancer and peritoneal metastases.
    BMC Cancer. 2025;25:616.
    >> Share

  125. ZHOU K, Hu X, Yang X, Wu Y, et al
    Clinicopathologic characteristics and prognostic factors of pure gastric neuroendocrine carcinoma patients undergoing radical surgery.
    BMC Cancer. 2025;25:606.
    >> Share

  126. SUN Y, Wen L, Xiang W, Luo X, et al
    Added value of pretreatment CT-based Node-RADS score for predicting survival outcome of locally advanced gastric cancer: compared with clinical N stage.
    BMC Cancer. 2025;25:598.
    >> Share

    March 2025
  127. WU Z, Wang X, Shi S, Kong D, et al
    Heterogeneity of T cells regulates tumor immunity mediated by Helicobacter pylori infection in gastric cancer.
    BMC Cancer. 2025;25:567.
    >> Share

  128. LAN Y, Sun W, Zhong S, Xu Q, et al
    A risk prediction model for gastric cancer based on endoscopic atrophy classification.
    BMC Cancer. 2025;25:518.
    >> Share

  129. HE QC, Huang ZN, Lv CB, Wu YH, et al
    Effect of Helicobacter pylori infection on survival outcomes of patients undergoing radical gastrectomy after neoadjuvant chemotherapy: a multicenter study in China.
    BMC Cancer. 2025;25:460.
    >> Share

  130. GAN X, Jia Y, Shan F, Ying X, et al
    Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trial.
    BMC Cancer. 2025;25:401.
    >> Share

  131. KANWAL W, Narjis K, Musani S, Nancy F, et al
    Exploring Zanidatamab's efficacy across HER2-positive Malignancies: a narrative review.
    BMC Cancer. 2025;25:382.
    >> Share

    February 2025
  132. XU M, Zhang Y, Zhao K, Jiang H, et al
    Prediction of pathological response to neoadjuvant immunochemotherapy with baseline and post-treatment (18)F-FDG PET imaging biomarkers in patients with locally advanced gastric cancer.
    BMC Cancer. 2025;25:378.
    >> Share

  133. WANG L, Chang Y, Ma J, Qu W, et al
    Identifying high-risk candidates for prolonging progression-free survival in primary gastric carcinoma subject to "double invasion": an analytical approach utilizing lasso-cox regression.
    BMC Cancer. 2025;25:381.
    >> Share

  134. PAN H, Sun H, Zuo Y, Zhao R, et al
    The prealbumin-CD19(+) index predicts surgical survival in patients with GC.
    BMC Cancer. 2025;25:359.
    >> Share

  135. QIAO Y, Kang B, Zhang Y, Song J, et al
    Short- and long-term outcomes of robotic- versus laparoscopic-assisted early-onset gastric cancer: a propensity score-matched retrospective cohort study.
    BMC Cancer. 2025;25:361.
    >> Share

  136. ENDO S, Higashida M, Fujiwara Y, Furuya K, et al
    Risk factors for postoperative pneumonia in older adults aged >/= 80 years with gastric cancer.
    BMC Cancer. 2025;25:342.
    >> Share

  137. SUN Y, Hou L, Zhao E
    Short-term outcomes of laparoscopic D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in distal gastric cancer patients with high body mass index.
    BMC Cancer. 2025;25:329.
    >> Share

  138. GU Y, Ma X, Xin H, Xiang Z, et al
    Navigating life after gastric cancer surgery: a qualitative exploration of the dyadic patient-caregiver perspective on quality of life outcomes.
    BMC Cancer. 2025;25:288.
    >> Share

  139. XU T, Huang J, Lin J, Liu Y, et al
    Correction: Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression.
    BMC Cancer. 2025;25:292.
    >> Share

  140. OU JY, Liu Y, Zhang L, Luo TQ, et al
    Assessing the quality and integrating the evidence and strength of recommendations in the guidelines for gastric precancerous lesions.
    BMC Cancer. 2025;25:272.
    >> Share

  141. LI X, Ding P, Wu J, Wu H, et al
    Preoperative sarcopenia and postoperative accelerated muscle loss negatively impact survival after resection of locally advanced gastric cancer.
    BMC Cancer. 2025;25:269.
    >> Share

  142. YEKTAKOOSHALI MH, SobhZahedi M, Razavi Tousi SMT, Hamidi M, et al
    Correction: Astaxanthin-loaded PLGA nanoparticles inhibit survival of MKN-45 gastric cancer cell line modulating JAK2/STAT3/mTOR/PI3K pathway.
    BMC Cancer. 2025;25:258.
    >> Share

  143. XU T, Huang J, Lin J, Liu Y, et al
    Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression.
    BMC Cancer. 2025;25:217.
    >> Share

  144. ZENG Y, Chen Y, Zhu D, Xu J, et al
    Machine learning assisted radiomics in predicting postoperative occurrence of deep venous thrombosis in patients with gastric cancer.
    BMC Cancer. 2025;25:220.
    >> Share

  145. HIRANO H, Takahashi N, Amanuma Y, Suzuki N, et al
    Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody (PADDLE)
    BMC Cancer. 2025;25:201.
    >> Share

  146. LI Y, Cao Y, Wang X, Li C, et al
    Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherap
    BMC Cancer. 2025;25:198.
    >> Share

  147. ZHANG XQ, Huang ZN, Wu J, Zheng CY, et al
    Development and validation of a prognostic prediction model for elderly gastric cancer patients based on oxidative stress biochemical markers.
    BMC Cancer. 2025;25:188.
    >> Share

    January 2025
  148. ZHONG B, Xiong Z, Zheng J, Mohamed SA, et al
    Impact of Helicobacter pylori infection on neoadjuvant chemotherapy in locally advanced gastric cancer: a retrospective analysis.
    BMC Cancer. 2025;25:157.
    >> Share

  149. YUAN J, Jiang Y, Chen F, Li T, et al
    Clinical implications of DNA ploidy, stroma, and nucleotyping in predicting peritoneal metastasis risk for gastric cancer.
    BMC Cancer. 2025;25:144.
    >> Share

  150. VARSHNEY N, Singh S, Kandpal M, Saini V, et al
    Interplay of aurora kinase a functional residues and Epstein-barr Nuclear Antigen 1 in Epstein-barr virus associated Gastric cancer using AGS cells.
    BMC Cancer. 2025;25:143.
    >> Share

  151. LI Y, Ma J, Cheng W
    Harnessing Machine Learning and Nomogram Models to Aid in Predicting Progression-Free Survival for Gastric Cancer Patients Post-Gastrectomy with Deficient Mismatch Repair(dMMR).
    BMC Cancer. 2025;25:141.
    >> Share

  152. NAJAFI S, Mohammadkhah F, Salemi SA, Kamyab A, et al
    The impact of educational intervention based on the theory of planned behavior on preventive behaviors for gastric cancer in obese and smoking individuals.
    BMC Cancer. 2025;25:129.
    >> Share

  153. SOWELL FG, de Milliano T, Brady KJS, Foglia G, et al
    A conceptual model for advanced/metastatic gastric or gastroesophageal junction cancer: a review of qualitative studies and results from patient interviews.
    BMC Cancer. 2025;25:88.
    >> Share

  154. XIAO Y, Zhu J, Xie H, Wang Z, et al
    Intratumoral and peritumoral radiomics for forecasting microsatellite status in gastric cancer: a multicenter study.
    BMC Cancer. 2025;25:66.
    >> Share

  155. YEKTAKOOSHALI MH, SobhZahedi M, Razavi Tousi SMT, Hamidi M, et al
    Astaxanthin-loaded PLGA nanoparticles inhibit survival of MKN-45 gastric cancer cell line by modulating JAK2/STAT3/mTOR/PI3K pathway.
    BMC Cancer. 2025;25:44.
    >> Share

  156. YIN C, Sun Y, Liang J, Sui X, et al
    Sedated and unsedated gastroscopy has no influence on the outcomes of patients with gastric cancer: a retrospective study.
    BMC Cancer. 2025;25:13.
    >> Share

  157. YU X, Shao Y, Dong H, Yan J, et al
    Molecular subtype of gastric cancer based on apoptosis-related genes reveals differential immune microenvironment and intratumoral microorganisms distribution.
    BMC Cancer. 2025;25:12.
    >> Share

    December 2024
  158. ZHANG YT, Wang SH, Zhao L, Wang HM, et al
    Screening and identification of vascular endothelial cell targeting peptide in gastric cancer through novel integrated in vitro and in vivo strategy.
    BMC Cancer. 2024;24:1595.
    >> Share

  159. IITAKA S, Kuroda A, Narita T, Hatakeyama H, et al
    Evaluation of N-NOSE as a surveillance tool for recurrence in gastric and esophageal cancers: a prospective cohort study.
    BMC Cancer. 2024;24:1544.
    >> Share

  160. MUDIYANSELAGE SB, Nguyen D, Tang B, Williams R, et al
    The epidemiological trends and predictions of esophageal squamous cell carcinoma and gastroesophageal junction carcinoma: an Australian population-based study.
    BMC Cancer. 2024;24:1498.
    >> Share

  161. LUO D, Xu H, Jiang C, Zheng J, et al
    Knowledge, attitudes, and practices of primary caregivers of gastric cancer patients regarding postoperative dietary management.
    BMC Cancer. 2024;24:1487.
    >> Share

  162. BRODKIN J, Kaprio T, Hagstrom J, Leppa A, et al
    Prognostic effect of immunohistochemically determined molecular subtypes in gastric cancer.
    BMC Cancer. 2024;24:1482.
    >> Share

    November 2024
  163. TIAN Y, Qiu S, Yang S, Jiang Y, et al
    The oncogenic role and prognostic value of PXDN in human stomach adenocarcinoma.
    BMC Cancer. 2024;24:1463.
    >> Share

  164. YU Z, Liang C, Li R, Xu Q, et al
    The impact of diabetes mellitus on short and long term outcomes in patients with gastric cancer following radical surgery: a retrospective cohort study with propensity score matching.
    BMC Cancer. 2024;24:1461.
    >> Share

  165. LIU SS, Wang JK, Liu MS, Guo DF, et al
    ILF2 protein is a promising serum biomarker for early detection of gastric cancer.
    BMC Cancer. 2024;24:1447.
    >> Share

  166. ABDI E, Latifi-Navid S, Kholghi-Oskooei V, Mostafaiy B, et al
    Roles of the lncRNAs MEG3, PVT1 and H19 tagSNPs in gastric cancer susceptibility.
    BMC Cancer. 2024;24:1440.
    >> Share

  167. ZHANG H, Yang W, Tan X, He W, et al
    Long-term relative survival of patients with gastric cancer from a large-scale cohort: a period-analysis.
    BMC Cancer. 2024;24:1420.
    >> Share

  168. MIYAMOTO H, Toyokawa T, Ishidate T, Kuroda K, et al
    Significance of the geriatric nutritional risk index and neutrophil-to-lymphocyte ratio as prognostic indicators in older patients with gastric cancer: a retrospective cohort study.
    BMC Cancer. 2024;24:1396.
    >> Share

  169. HE L, Gao X, Li T, Li X, et al
    Multicriteria optimization achieves superior normal tissue sparing in volumetric modulated arc therapy for gastric cancer.
    BMC Cancer. 2024;24:1376.
    >> Share

    October 2024
  170. LIU Y, Yang X, Wang Y, Xie S, et al
    Efficacy and safety of surufatinib in the treatment of patients with neuroendocrine tumor: a real-world study in Chinese population.
    BMC Cancer. 2024;24:1342.
    >> Share

  171. NIU X, Ma F, Li F, Wei C, et al
    Integration of bioinformatics and cellular experiments unveils the role of SYT12 in gastric cancer.
    BMC Cancer. 2024;24:1331.
    >> Share

  172. LIU YY, Tsai MY, Liu TT, Liu YW, et al
    The real-world efficacy and safety of nivolumab plus chemotherapy in patients with HER2-negative advanced gastric cancer.
    BMC Cancer. 2024;24:1325.
    >> Share

  173. SUN Y, Chen C, Hou L, Zhao E, et al
    Short-term outcomes and quality of life of esophagogastrostomy versus the double-tract reconstruction after laparoscopic proximal gastrectomy.
    BMC Cancer. 2024;24:1324.
    >> Share

  174. LI J, Ding F, Zhang S, Jia Y, et al
    Continuation of same programmed death-1 inhibitor regime beyond progression is a novel option for advanced gastric cancer.
    BMC Cancer. 2024;24:1292.
    >> Share

  175. YANG X, Zeng Z, Liao Z, Zhu C, et al
    Comparison of proximal gastrectomy and total gastrectomy in proximal gastric cancer: a meta-analysis of postoperative health condition using the PGSAS-45.
    BMC Cancer. 2024;24:1282.
    >> Share

    September 2024
  176. LIU F, Hu N, Jiang K, Liu H, et al
    Mutational signatures in 175 Chinese gastric cancer patients.
    BMC Cancer. 2024;24:1208.
    >> Share

  177. LIU ZK, Ma WX, Zhang JJ, Liu SD, et al
    Risk factor analysis and establishment of a predictive model for complications of elderly advanced gastric cancer with Clavien-Dindo classification >/= II grade.
    BMC Cancer. 2024;24:1185.
    >> Share

  178. ZHENG HL, Zhang LK, Lv CB, Xu BB, et al
    Impact of dynamic changes of tumor marker in neoadjuvant chemotherapy-treated triple-negative gastric cancer patients: a multi-center study.
    BMC Cancer. 2024;24:1188.
    >> Share

  179. FU L, Song L, Zhou X, Chen L, et al
    Serum metabolomics analysis of malnutrition in patients with gastric cancer: a cross sectional study.
    BMC Cancer. 2024;24:1195.
    >> Share

  180. LUAN X, Zhao L, Zhang F, Wang W, et al
    Sex disparity, prediagnosis lifestyle factors, and long-term survival of gastric cancer: a multi-center cohort study from China.
    BMC Cancer. 2024;24:1149.
    >> Share

  181. HE H, Dong K, Chen M, Wang Y, et al
    TOB1 inhibits the gastric cancer progression by focal adhesion pathway and ERK pathway based on transcriptional and metabolic sequencing.
    BMC Cancer. 2024;24:1130.
    >> Share

  182. INUKAI M, Nishi T, Matsuoka H, Matsuo K, et al
    Measurement of changes in serum-based inflammatory indicators to monitor response to nivolumab monotherapy in advanced gastric cancer: a multicenter retrospective study.
    BMC Cancer. 2024;24:1121.
    >> Share

  183. CHEN D, Tong W, Ang B, Bai Y, et al
    Revealing the crosstalk between LOX(+) fibroblast and M2 macrophage in gastric cancer by single-cell sequencing.
    BMC Cancer. 2024;24:1117.
    >> Share

  184. LUO D, Xu H, Jiang C, Zheng J, et al
    The prognostic role of palliative gastrectomy in advanced gastric cancer: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:1096.
    >> Share

  185. GOKON Y, Nakashima Y, Ohki Y, Ogino T, et al
    Prognostic significance of low HER2 expression in gastric cancer: a retrospective, single-center analysis.
    BMC Cancer. 2024;24:1081.
    >> Share

    August 2024
  186. WANG Y, Lei X, Shan F, Li S, et al
    Long-term outcomes of laparoscopic versus open total gastrectomy in patients with advanced gastric cancer after neoadjuvant chemotherapy: a retrospective cohort study.
    BMC Cancer. 2024;24:1074.
    >> Share

  187. WANG Y, Li W, Zhou CM, Zhao Z, et al
    Mortality risk of patients with intestinal obstruction.
    BMC Cancer. 2024;24:1062.
    >> Share

  188. CHEN Z, Zhang G, Liu Y, Zhu K, et al
    Radiomics analysis in predicting vascular invasion in gastric cancer based on enhanced CT: a preliminary study.
    BMC Cancer. 2024;24:1020.
    >> Share

  189. JIANG X, Qin L, Hao Y, Yang Q, et al
    The staining results of early gastric cancer by indigo carmine chromoendoscopy associated with histological structure: a retrospective study.
    BMC Cancer. 2024;24:1015.
    >> Share

  190. DING P, Yang J, Wu J, Wu H, et al
    Combined systemic inflammatory immune index and prognostic nutrition index as chemosensitivity and prognostic markers for locally advanced gastric cancer receiving neoadjuvant chemotherapy: a retrospective study.
    BMC Cancer. 2024;24:1014.
    >> Share

  191. XU L, Liu J, An Y, Zhou L, et al
    Glycolysis-related genes predict prognosis and indicate immune microenvironment features in gastric cancer.
    BMC Cancer. 2024;24:979.
    >> Share

  192. XIAO H, Fu J, Liu R, Yan L, et al
    Gastric cancer cell-derived exosomal miR-541-5p induces M2 macrophage polarization through DUSP3/JAK2/STAT3 pathway.
    BMC Cancer. 2024;24:957.
    >> Share

    July 2024
  193. WU Q, Li T, Cui Y, Jiang H, et al
    Unveiling clinicopathologic features and outcomes for endoscopic submucosal dissection of early gastric cancer at gastric angulus in China.
    BMC Cancer. 2024;24:924.
    >> Share

    June 2024
  194. ZENG Z, Li Y, Zhou H, Li M, et al
    System-wide identification of novel de-ubiquitination targets for USP10 in gastric cancer metastasis through multi-omics screening.
    BMC Cancer. 2024;24:773.
    >> Share

  195. ENDO S, Higashida M, Furuya K, Yano S, et al
    Prognostic factors for gastric cancer patients aged >/= 85 years.
    BMC Cancer. 2024;24:745.
    >> Share

  196. YU M, Peng J, Lu Y, Li S, et al
    Silencing immune-infiltrating biomarker CCDC80 inhibits malignant characterization and tumor formation in gastric cancer.
    BMC Cancer. 2024;24:724.
    >> Share

  197. ICHIKAWA H, Usui K, Aizawa M, Shimada Y, et al
    Clinical application of targeted tumour sequencing tests for detecting ERBB2 amplification and optimizing anti-HER2 therapy in gastric cancer.
    BMC Cancer. 2024;24:719.
    >> Share

  198. ZHANG S, Xu H, Li W, Cui J, et al
    Development and validation of an inflammatory biomarkers model to predict gastric cancer prognosis: a multi-center cohort study in China.
    BMC Cancer. 2024;24:711.
    >> Share

  199. LI X, Wang C, Wang Y, Chen X, et al
    Integrated analysis of the role of PR/SET domain 14 in gastric cancer.
    BMC Cancer. 2024;24:685.
    >> Share

  200. YE J, Ying J, Chen H, Wu Z, et al
    PPIH acts as a potential predictive biomarker for patients with common solid tumors.
    BMC Cancer. 2024;24:681.
    >> Share

    May 2024
  201. WANG J, Lin J, Wang R, Tong T, et al
    Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:603.
    >> Share

  202. PANG H, Dai L, Chen L, Chen X, et al
    Prognostic value of the advanced lung cancer inflammation index in patients with gastric cancer after radical gastrectomy: a propensity-score matching cohort study and meta-analysis.
    BMC Cancer. 2024;24:583.
    >> Share

  203. CHE B, Yuan S, Zhang H, Zhai J, et al
    Causal inference between pernicious anemia and cancers: a bidirectional two-sample mendelian randomization analysis.
    BMC Cancer. 2024;24:586.
    >> Share

  204. WANG S, Zhang W, Wu X, Zhu Z, et al
    Comprehensive analysis of T-cell regulatory factors and tumor immune microenvironment in stomach adenocarcinoma.
    BMC Cancer. 2024;24:570.
    >> Share

    April 2024
  205. ZHAN Z, Chen B, Cheng H, Xu S, et al
    Identification of prognostic signatures in remnant gastric cancer through an interpretable risk model based on machine learning: a multicenter cohort study.
    BMC Cancer. 2024;24:547.
    >> Share

  206. CHOI Y, Lee J, Shin K, Lee JW, et al
    Integrated clinical and genomic models using machine-learning methods to predict the efficacy of paclitaxel-based chemotherapy in patients with advanced gastric cancer.
    BMC Cancer. 2024;24:502.
    >> Share

  207. TAN Y, Feng LJ, Huang YH, Xue JW, et al
    Correction: Development and validation of a Radiopathomics model based on CT scans and whole slide images for discriminating between Stage I-II and Stage III gastric cancer.
    BMC Cancer. 2024;24:469.
    >> Share

  208. LIU SS, Wan QS, Lv C, Wang JK, et al
    Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer.
    BMC Cancer. 2024;24:465.
    >> Share

  209. LUNA J, Picker N, Wilke T, Lutz M, et al
    Real-world evidence of treatment patterns and survival of metastatic gastric cancer patients in Germany.
    BMC Cancer. 2024;24:462.
    >> Share

  210. LI F, Dou J, Wei L, Li S, et al
    Biomarkers of lipid metabolism in gastric cancer: a case control study.
    BMC Cancer. 2024;24:455.
    >> Share

  211. ZHONG Y, Xiao YY, Ye JY, Jian GL, et al
    Diagnostic efficacy of contrast-enhanced gastric ultrasonography in staging gastric cancer: a meta-analysis.
    BMC Cancer. 2024;24:422.
    >> Share

  212. ZHAN PC, Yang S, Liu X, Zhang YY, et al
    A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study.
    BMC Cancer. 2024;24:404.
    >> Share

    March 2024
  213. YOON C, Lu J, Jun Y, Suh YS, et al
    Retraction Note: KRAS activation in gastric cancer stem-like cells promotes tumor angiogenesis and metastasis.
    BMC Cancer. 2024;24:392.
    >> Share

  214. TAN Y, Feng LJ, Huang YH, Xue JW, et al
    Development and validation of a Radiopathomics model based on CT scans and whole slide images for discriminating between Stage I-II and Stage III gastric cancer.
    BMC Cancer. 2024;24:368.
    >> Share

  215. LIU D, Quan H, Ma M, Zhou H, et al
    Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study.
    BMC Cancer. 2024;24:344.
    >> Share

  216. CHEN Y, Chen X, Lin Y, Zhang S, et al
    Correction: Oncological risk of proximal gastrectomy for proximal advanced gastric cancer after neoadjuvant chemotherapy.
    BMC Cancer. 2024;24:314.
    >> Share

  217. WANG J, Shao M, Hu H, Xiao W, et al
    Convolutional neural network applied to preoperative venous-phase CT images predicts risk category in patients with gastric gastrointestinal stromal tumors.
    BMC Cancer. 2024;24:280.
    >> Share

    February 2024
  218. ZHANG J, Wang L, Zhang S, Cao R, et al
    Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients.
    BMC Cancer. 2024;24:266.
    >> Share

  219. CHEN Y, Chen X, Lin Y, Zhang S, et al
    Oncological risk of proximal gastrectomy for proximal advanced gastric cancer after neoadjuvant chemotherapy.
    BMC Cancer. 2024;24:255.
    >> Share

  220. LIM SH, Lee KW, Kim JJ, Im HS, et al
    Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06).
    BMC Cancer. 2024;24:252.
    >> Share

  221. LI ZZ, Yan XL, Zhang Z, Chen JL, et al
    Prognostic value of GLIM-defined malnutrition in combination with hand-grip strength or gait speed for the prediction of postoperative outcomes in gastric cancer patients with cachexia.
    BMC Cancer. 2024;24:253.
    >> Share

  222. DE MORAES FCA, Pasqualotto E, Chavez MP, Ferreira ROM, et al
    Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials.
    BMC Cancer. 2024;24:240.
    >> Share

  223. SUI H, Lou A, Li Z, Yang J, et al
    Retraction Note: Lidocaine inhibits growth, migration and invasion of gastric carcinoma cells by up-regulation of miR-145.
    BMC Cancer. 2024;24:241.
    >> Share

  224. ZHENG HL, Wang FH, Zhang LK, Li P, et al
    Trajectories of neutrophil-to-lymphocyte ratios during neoadjuvant chemotherapy correlate with short- and long-term outcomes in gastric cancer: a group-based trajectory analysis.
    BMC Cancer. 2024;24:226.
    >> Share

  225. FARAMARZI S, Kiani B, Faramarzi S, Firouraghi N, et al
    Cancer patterns in Iran: a gender-specific spatial modelling of cancer incidence during 2014-2017.
    BMC Cancer. 2024;24:191.
    >> Share

    January 2024
  226. HONG Z, Wen P, Wang K, Wei X, et al
    The macrophage-associated prognostic gene ANXA5 promotes immunotherapy resistance in gastric cancer through angiogenesis.
    BMC Cancer. 2024;24:141.
    >> Share

  227. WEI L, Wu X, Wang L, Chen L, et al
    Expression and prognostic value of APOBEC2 in gastric adenocarcinoma and its association with tumor-infiltrating immune cells.
    BMC Cancer. 2024;24:15.
    >> Share

  228. QU T, Zhang S, Yang S, Li S, et al
    Utilizing serum metabolomics for assessing postoperative efficacy and monitoring recurrence in gastric cancer patients.
    BMC Cancer. 2024;24:27.
    >> Share

    December 2023
  229. ZHU G, Cai H, Xiao Q, Zeng S, et al
    GRB7 plays a promoting role in the progression of gastric cancer.
    BMC Cancer. 2023;23:1262.
    >> Share

  230. CHE J, Zhao Y, Gu B, Li S, et al
    Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer.
    BMC Cancer. 2023;23:1238.
    >> Share

  231. NIE C, Xu W, Guo Y, Gao X, et al
    Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2-low advanced or metastatic gastric cancer: a multicenter real-world study.
    BMC Cancer. 2023;23:1239.
    >> Share

  232. GAO J, Lan J, Liao H, Yang F, et al
    Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges.
    BMC Cancer. 2023;23:1205.
    >> Share

  233. BOBRZYNSKI L, Sedlak K, Rawicz-Pruszynski K, Kolodziejczyk P, et al
    Evaluation of optimum classification measures used to define textbook outcome among patients undergoing curative-intent resection of gastric cancer.
    BMC Cancer. 2023;23:1199.
    >> Share

  234. JEON CH, Park KB, Lee H, Kim DJ, et al
    Refining gastric cancer staging: examining the interplay between number and anatomical location of metastatic lymph nodes - a retrospective multi-institutional study.
    BMC Cancer. 2023;23:1192.
    >> Share

    November 2023
  235. WEI C, He Y, Luo M, Chen G, et al
    The role of computed tomography features in assessing response to neoadjuvant chemotherapy in locally advanced gastric cancer.
    BMC Cancer. 2023;23:1157.
    >> Share

  236. ZHENG H, Yin X, Pan T, Tao X, et al
    Effect of different surgical approaches on the survival and safety of Siewert type II esophagogastric junction adenocarcinoma: a systematic review and meta-analysis.
    BMC Cancer. 2023;23:1130.
    >> Share

  237. CHEN YY, Li BP, Wang JF, Wang Y, et al
    Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer.
    BMC Cancer. 2023;23:1122.
    >> Share

  238. LIU X, Ren J, Zhou R, Wen Z, et al
    Construction of iron metabolism-related prognostic features of gastric cancer based on RNA sequencing and TCGA database.
    BMC Cancer. 2023;23:1106.
    >> Share

  239. YANG Y, Li Y, Chen Z
    Impact of low serum iron on treatment outcome of PD-1 inhibitors in advanced gastric cancer.
    BMC Cancer. 2023;23:1095.
    >> Share

  240. TAKASHIMA Y, Komatsu S, Nishibeppu K, Ohashi T, et al
    A shorter distal resection margin is a surrogate marker of nodal metastasis and poor prognosis in distal gastrectomy for advanced gastric cancer.
    BMC Cancer. 2023;23:1075.
    >> Share

    October 2023
  241. LUKSTA M, Bausys A, Bickaite K, Rackauskas R, et al
    Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patients with peritoneal metastases: single-arm phase II study.
    BMC Cancer. 2023;23:1032.
    >> Share

  242. QYI YZ, Aung HH, Aye SN, Tung WS, et al
    Toll-like receptor 9 (-1237 T/C, -1486 T/C) and the risk of gastric cancer: a meta-analysis of genetic association studies.
    BMC Cancer. 2023;23:1027.
    >> Share

  243. SUN C, Niu P, Zhang X, Zhao L, et al
    Concurrent clinical and pathological response predicts favorable prognosis of patients with gastric cancer after neoadjuvant therapy: a real-world study.
    BMC Cancer. 2023;23:996.
    >> Share

  244. MAKUUCHI R, Terashima M, Terada M, Mizusawa J, et al
    Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-4aN0-3 gastric cancer patients (JCOG1907, MONA LISA study): a study protocol.
    BMC Cancer. 2023;23:987.
    >> Share

  245. BEIHAGHI M, Sahebi R, Beihaghi MR, Nessiani RK, et al
    Evaluation of rs10811661 polymorphism in CDKN2A / B in colon and gastric cancer.
    BMC Cancer. 2023;23:985.
    >> Share

  246. NARA K, Yamamoto T, Yamashita H, Yagi K, et al
    Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab the
    BMC Cancer. 2023;23:979.
    >> Share

  247. WU D, Lu J, Xue Z, Zhong Q, et al
    Evaluation of dynamic recurrence risk for locally advanced gastric cancer in the clinical setting of adjuvant chemotherapy: a real-world study with IPTW-based conditional recurrence analysis.
    BMC Cancer. 2023;23:964.
    >> Share

  248. WANG Y, Guo Z, Tian Y, Cong L, et al
    MAPK1 promotes the metastasis and invasion of gastric cancer as a bidirectional transcription factor.
    BMC Cancer. 2023;23:959.
    >> Share

  249. XIANG L, Jin S, Yu Y, Wang D, et al
    Risk of venous thromboembolism in patients undergoing gastric cancer surgery: a systematic review and meta-analysis.
    BMC Cancer. 2023;23:933.
    >> Share

  250. WANG Y, Pan J, An F, Chen K, et al
    GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer.
    BMC Cancer. 2023;23:925.
    >> Share

  251. XIA B, Gu X, Xu T, Yan M, et al
    Exosomes-mediated transfer of LINC00691 regulates the formation of CAFs and promotes the progression of gastric cancer.
    BMC Cancer. 2023;23:928.
    >> Share

    September 2023
  252. KIM Y, Bae YJ, Kim JH, Kim H, et al
    Wnt/beta-catenin pathway is a key signaling pathway to trastuzumab resistance in gastric cancer cells.
    BMC Cancer. 2023;23:922.
    >> Share

  253. SUN Y, Chen C, Hou L, Zhao E, et al
    Short-term and long-term outcomes of patients with gastric cancer during versus before the COVID-19 pandemic: cohort study using propensity score matching method.
    BMC Cancer. 2023;23:913.
    >> Share

  254. WU J, Tian S, Xu J, Cheng N, et al
    Association of high-risk comorbidity with overall survival among patients with gastric cancer and its sex-specific differences in China: a retrospective observational cohort study.
    BMC Cancer. 2023;23:916.
    >> Share

  255. SAHIN MEH, Akbas F, Yardimci AH, Sahin E, et al
    The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer.
    BMC Cancer. 2023;23:911.
    >> Share

  256. MA X, Pierce E, Anand H, Aviles N, et al
    Early prediction of response to palliative chemotherapy in patients with stage-IV gastric and esophageal cancer.
    BMC Cancer. 2023;23:910.
    >> Share

  257. ZHAO L, Zhang F, Jiao F, Zhou X, et al
    The minimum number of examined lymph nodes was 24 for optimal survival of pathological T2-4 gastric cancer: a multi-center, hospital-based study covering 20 years of data.
    BMC Cancer. 2023;23:892.
    >> Share

    August 2023
  258. HIGUCHI S, Suehiro Y, Izuhara L, Yoshina S, et al
    BCL7B, a SWI/SNF complex subunit, orchestrates cancer immunity and stemness.
    BMC Cancer. 2023;23:811.
    >> Share

  259. DI Y, Ding L, Gao L, Huang H, et al
    Association of meat consumption with the risk of gastrointestinal cancers: a systematic review and meta-analysis.
    BMC Cancer. 2023;23:782.
    >> Share

  260. SHIH YH, Lin HC, Liao PW, Chou CW, et al
    The efficacy of adjuvant chemotherapy for older adults with stage II/III gastric cancer: a retrospective cohort study.
    BMC Cancer. 2023;23:770.
    >> Share

  261. HAN Y, Wu J, Ji R, Tan H, et al
    Preoperative sarcopenia combined with prognostic nutritional index predicts long-term prognosis of radical gastrectomy with advanced gastric cancer: a comprehensive analysis of two-center study.
    BMC Cancer. 2023;23:751.
    >> Share

  262. TAKAHASHI N, Hara H, Nagashima K, Hirata K, et al
    Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G).
    BMC Cancer. 2023;23:726.
    >> Share

    July 2023
  263. YOON C, Lu J, Jun Y, Suh YS, et al
    KRAS activation in gastric cancer stem-like cells promotes tumor angiogenesis and metastasis.
    BMC Cancer. 2023;23:690.
    >> Share

  264. YANAGIMOTO Y, Imamura H, Adachi S, Odagiri K, et al
    The effect of specimen processing time on HER2 expression in gastric cancer and esophagogastric junction cancer: a single-center retrospective observational study.
    BMC Cancer. 2023;23:645.
    >> Share

    June 2023
  265. HAN Y, Wang X, Xu M, Teng Z, et al
    Aspartoacylase promotes the process of tumour development and is associated with immune infiltrates in gastric cancer.
    BMC Cancer. 2023;23:604.
    >> Share

  266. JEON CH, Park KB, Kim S, Seo HS, et al
    Predictive model for long-term weight recovery after gastrectomy for gastric cancer: an introduction to a web calculator.
    BMC Cancer. 2023;23:580.
    >> Share

  267. LORENZEN S, Schwarz A, Pauligk C, Goekkurt E, et al
    Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/I
    BMC Cancer. 2023;23:561.
    >> Share

  268. SHEN X, Liu H, Zhou H, Cheng Z, et al
    Galectin-1 promotes gastric cancer peritoneal metastasis through peritoneal fibrosis.
    BMC Cancer. 2023;23:559.
    >> Share

  269. TIAN Y, Pang Y, Yang PG, Guo HH, et al
    Clinical implications of micro lymph node metastasis for patients with gastric cancer.
    BMC Cancer. 2023;23:536.
    >> Share

  270. E Y, Yu Q, Sun T, Xue H, et al
    The relationship between pepsinogen C and gastric carcinogenesis: a transgene and population study.
    BMC Cancer. 2023;23:520.
    >> Share

  271. LI Y, Wu G, Liu J, Zhang Y, et al
    Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis.
    BMC Cancer. 2023;23:523.
    >> Share

  272. DU Y, Yu X, Chang ET, Yin L, et al
    EBV antibody and gastric cancer risk: a population-based nested case-control study in southern China.
    BMC Cancer. 2023;23:521.
    >> Share

  273. ZHAO Z, Zhu Y
    FAP, CD10, and GPR77-labeled CAFs cause neoadjuvant chemotherapy resistance by inducing EMT and CSC in gastric cancer.
    BMC Cancer. 2023;23:507.
    >> Share

    May 2023
  274. LEONG E, Ong SK, Si-Ramlee KA, Naing L, et al
    Cancer incidence and mortality in Brunei Darussalam, 2011 to 2020.
    BMC Cancer. 2023;23:466.
    >> Share

  275. XU D, Liu X, Ke S, Guo Y, et al
    CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer.
    BMC Cancer. 2023;23:464.
    >> Share

  276. ZHANG H, Wang H, Ye L, Bao S, et al
    Comprehensive transcriptomic analyses identify KDM genes-related subtypes with different TME infiltrates in gastric cancer.
    BMC Cancer. 2023;23:454.
    >> Share

  277. HAMADA T, Higashi M, Yokoyama S, Akahane T, et al
    MALAT1 functions as a transcriptional promoter of MALAT1::GLI1 fusion for truncated GLI1 protein expression in cancer.
    BMC Cancer. 2023;23:424.
    >> Share

  278. YANG H, Wang JB, Wang XK, Fan JH, et al
    Association between type of drinking water and upper gastrointestinal cancer incidence in the Linxian General Population.
    BMC Cancer. 2023;23:397.
    >> Share

    April 2023
  279. LIU Y, Shen S, Yan Z, Yan L, et al
    Expression characteristics and their functional role of IGFBP gene family in pan-cancer.
    BMC Cancer. 2023;23:371.
    >> Share

  280. CUI Y, Yu Y, Zheng S, Ying J, et al
    Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA).
    BMC Cancer. 2023;23:308.
    >> Share

    March 2023
  281. WANG H, Cui H, Yang X, Peng L, et al
    TUBA1C: a new potential target of LncRNA EGFR-AS1 promotes gastric cancer progression.
    BMC Cancer. 2023;23:258.
    >> Share

  282. YANG J, Li J, Deng Q, Chen Z, et al
    Effect of neoadjuvant chemotherapy combined with arterial chemoembolization on short-term clinical outcome of locally advanced gastric cancer.
    BMC Cancer. 2023;23:246.
    >> Share

  283. KAMIYA H, Komatsu S, Nishibeppu K, Ohashi T, et al
    Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction.
    BMC Cancer. 2023;23:218.
    >> Share

  284. ZHANG L, Wang W, Ge S, Li H, et al
    Sintilimab Plus Apatinib and Chemotherapy as Second‑/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a prospective, Single-Arm, phase II trial.
    BMC Cancer. 2023;23:211.
    >> Share

    February 2023
  285. XIAO H, Bertwistle D, Khela K, Middleton-Dalby C, et al
    Global retrospective analysis of clinician- and patient-reported clinical characteristics and humanistic burden of patients with gastroesophageal cancers on first-line treatment.
    BMC Cancer. 2023;23:186.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016